Vir Biotechnology Inc.

NASDAQ: VIR · Real-Time Price · USD
4.51
0.07 (1.58%)
At close: Aug 15, 2025, 3:59 PM
4.49
-0.43%
After-hours: Aug 15, 2025, 07:24 PM EDT

Vir Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-521.96M -615.06M 515.84M 528.58M
Depreciation & Amortization
14.56M 19.45M 6.78M 5.81M
Stock-Based Compensation
78.46M 111.32M 102.08M 83.78M
Other Working Capital
-76.51M -305.32M -105.47M 92.04M
Other Non-Cash Items
69.55M 11.16M 388.37M -52.56M
Deferred Income Tax
-2.95M -1.06M -15.19M 15.19M
Change in Working Capital
-84.01M -304.59M 665.37M -628.39M
Operating Cash Flow
-446.35M -778.78M 1.66B -47.59M
Capital Expenditures
-7.3M -21.57M -68.03M -21.82M
Cash Acquisitions
n/a n/a 22K 140.81M
Purchase of Investments
-1.24B -2.02B -1.48B -420.24M
Sales Maturities Of Investments
1.74B 2.2B 351.51M 301.24M
Other Investing Acitivies
3.37M n/a -1.13B -140.81M
Investing Cash Flow
499.37M 164.63M -1.19B -140.81M
Debt Repayment
n/a -287K -260K -259K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.39M 7.77M 6.56M 15.38M
Financial Cash Flow
4.39M 7.48M 34.76M 100.33M
Net Cash Flow
57.4M -606.68M 504.55M -88.07M
Free Cash Flow
-453.65M -800.36M 1.6B -69.41M